Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2200065977Phase 4Recruiting
Phase 4, randomised trial of remimazolam in bronchoscopy sedation (4 arms), sponsored by Fifth Affiliated Hospital of Southern Medical University. Primary endpoints: Sedation effect and Cognitive function (MOAA/S). Started Sep 2022; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2200065977.